Finance Watch: OrbiMed’s New $1.86bn Fund Offers Financial Alternatives In Tough Market

Nasus Raises $10m In Eighth US IPO Of 2025

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.